Evidence for a role of microRNA-146a in the pathogenesis of systemic lupus erythematosus with atherosclerosis: Comment on the article by Li et al

Arthritis and Rheumatism

Volumn 64, Issue 1, 2012, Pages 323-324

  Xu, Wang Dong ^a   Zhang, Yu Jing ^a   Ye, Dong Qing ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIINFLAMMATORY AGENT; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 1; MICRORNA; MICRORNA 146A; SCAVENGER RECEPTOR A; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ATHEROSCLEROSIS; GENE EXPRESSION REGULATION; HUMAN; LETTER; MOLECULAR PATHOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS; TRANSCRIPTION REGULATION; TRANSLATION REGULATION;

ATHEROSCLEROSIS; FEMALE; FOAM CELLS; HUMANS; INTERFERON-ALPHA; LIPID METABOLISM; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; SCAVENGER RECEPTORS, CLASS A;

EID: 84855281825     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.33356     Document Type: Letter

References (11)

1. Li J, Fu Q, Cui H, Qu B, Pan W, Shen N, et al. Interferon-α priming promotes lipid uptake and macrophage-derived foam cell formation. Arthritis Rheum 2011; 63: 492-502.
2. Yang K, He YS, Wang XQ, Lu L, Chen QJ, Liu J, et al. MiR-146a inhibits oxidized low-density lipoprotein-induced lipid accumulation and in ammatory response via targeting toll-like receptor 4. FEBS Lett 2011; 585: 854-60.
3. O'Connell RM, Taganov KD, Boldin MP, Cheng G, Baltimore D,. MicroRNA-155 is induced during the macrophage inflammatory response. Proc Natl Acad Sci U S A 2007; 104: 1604-9. (Pubitemid 46214637)
4. Taganov KD, Boldin MP, Chang KJ, Baltimore D,. NF-κB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci U S A 2006; 103: 12481-6. (Pubitemid 44267285)
5. Nahid MA, Satoh M, Chan EK,. Mechanistic role of microRNA-146a in endotoxin-induced differential cross-regulation of TLR signaling. J Immunol 2011; 186: 1723-34.
6. Moreth K, Brodbeck R, Babelova A, Gretz N, Spieker T, Zeng-Brouwers J, et al. The proteoglycan biglycan regulates expression of the B cell chemoattractant CXCL13 and aggravates murine lupus nephritis. J Clin Invest 2010; 120: 4251-72.
7. Richez C, Blanco P, Rifkin I, Moreau JF, Schaeverbeke T,. Role for toll-like receptors in autoimmune disease: the example of systemic lupus erythematosus. Joint Bone Spine 2011; 78: 124-30.
8. Lee TP, Tang SJ, Wu MF, Song YC, Yu CL, Sun KH,. Transgenic overexpression of anti-double-stranded DNA autoantibody and activation of Toll-like receptor 4 in mice induce severe systemic lupus erythematosus syndromes. J Autoimmun 2010; 35: 358-67.
9. Wang HY, Li Y, Chen MH, Hui Z,. Expression of microRNA-146a in peripheral blood mononuclear cells in patients with systemic lupus erythematosus. Acta Academiae Medicine Sinicae 2011; 33: 185-8.
10. Zhang J, Yang B, Ying B, Li D, Shi Y, Song X, et al. Association of pre-microRNAs genetic variants with susceptibility in systemic lupus erythematosus. Mol Biol Rep. 2011; 38: 1463-8.
11. Tang Y, Luo X, Cui H, Ni X, Yuan M, Guo Y, et al. MicroRNA-146a contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins. Arthritis Rheum 2009; 60: 1065-75.